Posted on 15 December 2019
Michael Davitz spoke on a panel at the American Conference Institute’s 3rd Annual Summit on Life Sciences in IP Due Diligence on November 15, 2019 at the OMNI Parker House in Boston, MA. The panel addressed “When Faulty IP Diligence Kills the Deal: If I Knew Then What I Know Now”. The event was an interactive forum where top diligence experts discussed best practices and strategies for performing proper IP due diligence analysis for key life science company stakeholders. See https://www.americanconference.com/life-sciences-ip-due-diligence/.